How much would the generic V ..off label ...cost you ?
Your post is a classic example of how confusing our systems for heath coverage is .
Why should you be subsidized in any way for an off label script ? Show me an ICER report detailing the cost / benefit analysis of any "off label "Vascepa program. Right ...theres none ...Theres no savings to the insurer by providing you low cost coverage ...so why should they.
We need low cost coverage for those at highest risk ...R-IT profile , diabetics with prior events.......for example ...an indication that by the way is patent protected .